Celldex (CLDX) Misses Q3 EPS by 13c

Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.81), $0.13 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.51 million versus the consensus estimate of $583.33 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target